Cargando…
Metformin inhibits cervical cancer cell proliferation by modulating PI3K/Akt-induced major histocompatibility complex class I-related chain A gene expression
BACKGROUND: Recent studies have shown that the classic hypoglycemic drug metformin inhibits tumor growth; however, the underlying mechanism remains unclear. We previously showed that metformin disrupts the sponge effect of long non-coding RNA MALAT1/miR-142-3p to inhibit cervical cancer cell prolife...
Autores principales: | Xia, Chenglai, Liu, Chang, He, Zhihong, Cai, Yantao, Chen, Jinman |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7336474/ https://www.ncbi.nlm.nih.gov/pubmed/32631421 http://dx.doi.org/10.1186/s13046-020-01627-6 |
Ejemplares similares
-
Quantitative proteomics analysis of differentially expressed proteins induced by astragaloside IV in cervical cancer cell invasion
por: Xia, Chenglai, et al.
Publicado: (2020) -
Invariant chain cleavage and peptide loading in major histocompatibility complex class II vesicles
Publicado: (1995) -
Combining metformin and nelfinavir exhibits synergistic effects against the growth of human cervical cancer cells and xenograft in nude mice
por: Xia, Chenglai, et al.
Publicado: (2017) -
Metformin inhibits the proliferation of A431 cells by modulating the PI3K/Akt signaling pathway
por: LIU, YINGSHAN, et al.
Publicado: (2015) -
Metformin inhibits the proliferation of A431 cells by modulating the PI3K/Akt signaling pathway
por: Liu, Yingshan, et al.
Publicado: (2022)